UnitedHealths 33B Deal With Hospice Provider Blocked By DOJ
| AMED Stock | USD 90.79 0.30 0.33% |
About 55% of Amedisys' investor base is interested to short. The analysis of overall sentiment of trading Amedisys stock suggests that many investors are impartial at this time. The current market sentiment, together with Amedisys' historical and current headlines, can help investors time the market. In addition, many technical investors use Amedisys stock news signals to limit their universe of possible portfolio assets.
Amedisys |
The United States Department of Justice is suing to block UnitedHealth Groups 3.3 billion acquisition of Amedisys, arguing that it would harm competition.
Read at ibtimes.com
 |
Amedisys Fundamental Analysis
We analyze Amedisys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Amedisys is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Amedisys Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amedisys stock to make a market-neutral strategy. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics with similar companies.
Peers
Amedisys Related Equities
| SGRY | Surgery Partners | 2.92 | ||||
| ACHC | Acadia Healthcare | 2.77 | ||||
| OPCH | Option Care | 2.38 | ||||
| EHAB | Enhabit | 1.56 | ||||
| PNTG | Pennant | 1.14 | ||||
| HCSG | Healthcare Services | 0.87 | ||||
| UHS | Universal Health | 0.59 | ||||
| NHC | National HealthCare | 0.13 | ||||
| ENSG | Ensign | 0.11 | ||||
| EHC | Encompass Health | 0.08 | ||||
| INNV | InnovAge Holding | 0.51 | ||||
| ADUS | Addus HomeCare | 0.74 |
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |